We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Trump’s Pick for HHS Tells Senate Drug Prices are Too High
Trump’s Pick for HHS Tells Senate Drug Prices are Too High
President Trump’s nominee for the next secretary of HHS, former Eli Lilly executive Alex Azar, told the Senate’s health committee he agrees prescription drug prices are too high, and would welcome congressional action if appointed to the post.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor